15 Jun 2022 by admin in UncategorizedComments Arcellx Announces Upsizing And Pricing Of Follow-On Public Offering
09 Jun 2022 by admin in UncategorizedComments Tempest Provides ASCO KOL Feedback on TPST-1120 Clinical Results and Updated Financial Guidance
23 May 2022 by admin in UncategorizedComments Arcellx Appoints Michelle Gilson As Chief Financial Officer
16 May 2022 by admin in UncategorizedComments Syros Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides a Corporate Update
13 May 2022 by admin in UncategorizedComments Tempest Reports First Quarter 2022 Financial Results and Provides Corporate Highlights
12 May 2022 by admin in UncategorizedComments Arcellx Provides Business Updates and Reports First Quarter 2022 Financial Results